
Imclone (NASDAQ IMCL) is rallying amid reports of positive Erbitux data.
IMCL hit an intra day high of $47.22, the highest level since January 2005.
Tuesday, September 11, 2007
at
7:16 AM
Labels: biotech, biotech stocks, NASDAQ, new 52 week high, technical analysis